NASDAQ:LYEL | Total Liabilities | Lyell Immunopharma, Inc.

Complete source-backed total liabilities history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Total Liabilities

DateTotal liabilitiesCurrent liabilitiesAccounts payableNoncurrent debtOther noncurrent liabilities
2026-06-30$77.34M$39.87M$3.88M$537,000.00
2026-03-31$76.96M$36.95M$5.47M$527,000.00
2025-12-31$91.85M$49.41M$2.89M$517,000.00
2025-09-30$78.84M$31.88M$2.57M$2.68M
2025-06-30$86.53M$36.9M$3.38M$3.03M
2025-03-31$93.28M$41.29M$3.73M$3.14M
2024-12-31$108.04M$53.79M$5.37M$3.25M
2024-09-30$88.52M$33.51M$3.6M$3.57M
2024-06-30$87.64M$30.88M$4.2M$3.44M
2024-03-31$91.06M$32.35M$4.9M$3.55M
2023-12-31$95.08M$34.52M$4.82M$3.66M
2023-09-30$97.42M$35.06M$4.37M$3.78M
2023-06-30$98.5M$34.39M$5.81M$3.89M
2023-03-31$96.62M$30.8M$5.73M$4M
2022-12-31$104.31M$37.03M$3.92M$4.11M
2022-09-30$157.24M$51.22M$4.8M$4.23M
2022-06-30$153.63M$50.29M$4.25M$4.34M
2022-03-31$190.85M$41.06M$6.51M$4.45M
2021-12-31$197.62M$46.74M$3.21M$4.57M
2021-09-30$211.86M$59.28M$3.53M$5.01M
2021-06-30$207.91M$63.66M$4.86M$900,000.00
2020-12-31$189.84M$49.29M$9.4M$532,000.00